S'inscrire | Se connecter | FAQ      [?] 

Nature Biotechnology

Articles from the last few issues of Nature Biotechnology © Nature Publishing Group
  • EGFR inhibitors embrace KRAS
    Nature Biotechnology, Vol. 26, No. 8., pp. 839-840.
    by Cormac Sheridan
  • GSK slashes internal R&D
    Nature Biotechnology, Vol. 26, No. 8., pp. 840-840.
    by Nuala Moran
  • Myriad stumbles, Wyeth closes on Alzheimer's
    Nature Biotechnology, Vol. 26, No. 8., pp. 841-843.
    by Randy Osborne
  • FDA and surrogate endpoints in Alzheimer's disease
    Nature Biotechnology, Vol. 26, No. 8., pp. 843-843.
    by Randy Osborne
  • Infections cast cloud over Novartis' MS therapy
    Nature Biotechnology, Vol. 26, No. 8., pp. 844-845.
    by Ken Garber
  • India harmonizes regulations
    Nature Biotechnology, Vol. 26, No. 8., pp. 845-845.
    by KS Jayaraman
  • FDA probes TNF blockers
    Nature Biotechnology, Vol. 26, No. 8., pp. 845-845.
    by Brady Huggett
  • GSK bird flu vaccine
    Nature Biotechnology, Vol. 26, No. 8., pp. 846-846.
    by Susan Aldridge
  • Cabilly patent finale
    Nature Biotechnology, Vol. 26, No. 8., pp. 846-846.
    by Emily Waltz
  • UK strong arms industry over drug pricing
    Nature Biotechnology, Vol. 26, No. 8., pp. 846-847.
    by Peter Mitchell
  • Pharma to boycott UK?
    Nature Biotechnology, Vol. 26, No. 8., pp. 847-847.
    by Peter Mitchell
  • EC/FDA joint inspections
    Nature Biotechnology, Vol. 26, No. 8., pp. 847-847.
    by Barbara Nasto
  • Supply size matters
    Nature Biotechnology, Vol. 26, No. 8., pp. 847-847.
    by Susan Aldridge
  • Profile: Olivier Rabin
    Nature Biotechnology, Vol. 26, No. 8., pp. 849-849.
    by Henry Nicholls
  • Q2 finance fall-off
    Nature Biotechnology, Vol. 26, No. 8., pp. 850-850.
    by Stacy Lawrence
  • Do biomaterials really mean business?
    Nature Biotechnology, Vol. 26, No. 8., pp. 851-853.
    by Emily Waltz
  • The economics of licensing contracts
    Nature Biotechnology, Vol. 26, No. 8. (11 July 2008), pp. 855-857.
    by Richard Mason, Nicos Savva, Stefan Scholtes
  • GMO testing—trade, labeling or safety first?
    Nature Biotechnology, Vol. 26, No. 8., pp. 858-859.
    by Arne Holst-Jensen
  • First evaluation of the European hESCreg
    Nature Biotechnology, Vol. 26, No. 8., pp. 859-860.
    by Joeri Borstlap, Glyn Stacey, Andreas Kurtz, Anja Elstner, Alexander Damaschun, Begoña Arán, Anna Veiga
  • Guidelines for reporting the use of mass spectrometry in proteomics
    Nature Biotechnology, Vol. 26, No. 8., pp. 860-861.
    by Chris F Taylor, Pierre-Alain Binz, Ruedi Aebersold, Michel Affolter, Robert Barkovich, Eric W Deutsch, David M Horn, Andreas Hühmer, Martin Kussmann, Kathryn Lilley, Marcus Macht, Matthias Mann, Dieter Müller, Thomas A Neubert, Janice Nickson, Scott D Patterson, Roberto Raso, Kathryn Resing, Sean L Seymour, Akira Tsugita, Ioannis Xenarios, Rong Zeng, Randall K Julian
  • Guidelines for reporting the use of mass spectrometry informatics in proteomics
    Nature Biotechnology, Vol. 26, No. 8., pp. 862-862.
    by Pierre-Alain Binz, Robert Barkovich, Ronald C Beavis, David Creasy, David M Horn, Randall K Julian, Sean L Seymour, Chris F Taylor, Yves Vandenbrouck
  • Guidelines for reporting the use of gel electrophoresis in proteomics
    Nature Biotechnology, Vol. 26, No. 8., pp. 863-864.
    by Frank Gibson, Leigh Anderson, Gyorgy Babnigg, Mark Baker, Matthias Berth, Pierre-Alain Binz, Andy Borthwick, Phil Cash, Billy W Day, David B Friedman, Donita Garland, Howard B Gutstein, Christine Hoogland, Neil A Jones, Alamgir Khan, Joachim Klose, Angus I Lamond, Peter F Lemkin, Kathryn S Lilley, Jonathan Minden, Nicholas J Morris, Norman W Paton, Michael R Pisano, John E Prime, Thierry Rabilloud, David A Stead, Chris F Taylor, Hans Voshol, Anil Wipat, Andrew R Jones
    posted by 2 people fgibson GelML
  • The PSI-MOD community standard for representation of protein modification data
    Nat Biotech, Vol. 26, No. 8. (2008), pp. 864-866.
    by Luisa Montecchi-Palazzi, Ron Beavis, Pierre-Alain Binz, Robert J Chalkley, John Cottrell, David Creasy, Jim Shofstahl, Sean L Seymour, John S Garavelli
    posted by 1 person GeeSharpMinor
  • Off-label or off-limits?
    Nature Biotechnology, Vol. 26, No. 8., pp. 867-875.
    by Mark Ratner, Trisha Gura
  • The London Agreement and the future of parallel imports
    Nature Biotechnology, Vol. 26, No. 8., pp. 877-879.
    by Justine Muir
  • Sequencing sliced ends reveals microRNA targets
    Nature Biotechnology, Vol. 26, No. 8., pp. 881-882.
    by Ian R Henderson, Steven E Jacobsen
  • Nematology: terra incognita no more
    Nature Biotechnology, Vol. 26, No. 8., pp. 882-884.
    by James P Mccarter
  • Antibody-drug conjugates ace the tolerability test
    Nature Biotechnology, Vol. 26, No. 8., pp. 884-885.
    by Nitin K Damle
  • A welcome burst of human antibodies
    Nat Biotech, Vol. 26, No. 8. (2008), pp. 886-887.
    by Michael B Zwick, Johannes S Gach, Dennis R Burton
    posted by 1 person GeeSharpMinor
  • Promoting coherent minimum reporting guidelines for biological and biomedical investigations: the MIBBI project
    Nat Biotech, Vol. 26, No. 8. (2008), pp. 889-896.
    by Chris F Taylor, Dawn Field, Susanna-Assunta Sansone, Jan Aerts, Rolf Apweiler, Michael Ashburner, Catherine A Ball, Pierre-Alain Binz, Molly Bogue, Tim Booth, Alvis Brazma, Ryan R Brinkman, Michael, Eric W Deutsch, Oliver Fiehn, Jennifer Fostel, Peter Ghazal, Frank Gibson, Tanya Gray, Graeme Grimes, John M Hancock, Nigel W Hardy, Henning Hermjakob, Randall K Julian, Matthew Kane, Carsten Kettner, Christopher Kinsinger, Eugene Kolker, Martin Kuiper, Nicolas L Novere, Jim Leebens-Mack, Suzanna E Lewis, Phillip Lord, Ann-Marie Mallon, Nishanth Marthandan, Hiroshi Masuya, Ruth Mcnally, Alexander Mehrle, Norman Morrison, Sandra Orchard, John Quackenbush, James M Reecy, Donald G Robertson, Philippe Rocca-Serra, Henry Rodriguez, Heiko Rosenfelder, Javier Santoyo-Lopez, Richard H Scheuermann, Daniel Schober, Barry Smith, Jason Snape, Christian J Stoeckert, Keith Tipton, Peter Sterk, Andreas Untergasser, Jo Vandesompele, Stefan Wiemann
    posted by 8 people jandot dullhunk GelML GeeSharpMinor ChrisEvelo lenov fgibson renatomilani
  • What is the expectation maximization algorithm?
    Nat Biotech, Vol. 26, No. 8. (2008), pp. 897-899.
    by Chuong B Do, Serafim Batzoglou
    posted by 5 people Tominator GeeSharpMinor jyuh zwang phoenixzxl
  • Neutralizing antibodies to therapeutic enzymes: considerations for testing, prevention and treatment
    Nature Biotechnology, Vol. 26, No. 8. (07 August 2008), pp. 901-908.
    by Jinhai Wang, Jay Lozier, Gibbes Johnson, Susan Kirshner, Daniela Verthelyi, Anne Pariser, Elizabeth Shores, Amy Rosenberg
  • Genome sequence of the metazoan plant-parasitic nematode Meloidogyne incognita.
    Nature biotechnology (27 July 2008)
    by Pierre Abad, Jérôme Gouzy, Jean-Marc M Aury, Philippe Castagnone-Sereno, Etienne G J G Danchin, Emeline Deleury, Laetitia Perfus-Barbeoch, Véronique Anthouard, François Artiguenave, Vivian C C Blok, Marie-Cécile C Caillaud, Pedro M M Coutinho, Corinne Dasilva, Francesca De Luca, Florence Deau, Magali Esquibet, Timothé Flutre, Jared V V Goldstone, Noureddine Hamamouch, Tarek Hewezi, Olivier Jaillon, Claire Jubin, Paola Leonetti, Marc Magliano, Tom R R Maier, Gabriel V V Markov, Paul McVeigh, Graziano Pesole, Julie Poulain, Marc Robinson-Rechavi, Erika Sallet, Béatrice Ségurens, Delphine Steinbach, Tom Tytgat, Edgardo Ugarte, Cyril van Ghelder, Pasqua Veronico, Thomas J J Baum, Mark Blaxter, Teresa Bleve-Zacheo, Eric L L Davis, Jonathan J J Ewbank, Bruno Favery, Eric Grenier, Bernard Henrissat, John T T Jones, Vincent Laudet, Aaron G G Maule, Hadi Quesneville, Marie-Noëlle N Rosso, Thomas Schiex, Geert Smant, Jean Weissenbach, Patrick Wincker
    posted by 2 people timflutre zwang
  • A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types
    Nature Biotechnology, Vol. 26, No. 8. (01 July 2008), pp. 916-924.
    by Marius Wernig, Christopher J Lengner, Jacob Hanna, Michael A Lodato, Eveline Steine, Ruth Foreman, Judith Staerk, Styliani Markoulaki, Rudolf Jaenisch
    posted by 2 people wsjames Oxford Virology
  • Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index
    Nature Biotechnology, Vol. 26, No. 8. (20 July 2008), pp. 925-932.
    by Jagath R Junutula, Helga Raab, Suzanna Clark, Sunil Bhakta, Douglas D Leipold, Sylvia Weir, Yvonne Chen, Michelle Simpson, Siao P Tsai, Mark S Dennis, Yanmei Lu, Gloria Y Meng, Carl Ng, Jihong Yang, Chien C Lee, Eileen Duenas, Jeffrey Gorrell, Viswanatham Katta, Amy Kim, Kevin Mcdorman, Kelly Flagella, Rayna Venook, Sarajane Ross, Susan D Spencer, Wai L Wong, Henry B Lowman, Richard Vandlen, Mark X Sliwkowski, Richard H Scheller, Paul Polakis, William Mallet
    posted by 1 person kengg
  • A small molecule enhances RNA interference and promotes microRNA processing
    Nature Biotechnology, Vol. 26, No. 8. (20 July 2008), pp. 933-940.
    by Ge Shan, Yujing Li, Junliang Zhang, Wendi Li, Keith E Szulwach, Ranhui Duan, Mohammad A Faghihi, Ahmad M Khalil, Lianghua Lu, Zain Paroo, Anthony WS Chan, Zhangjie Shi, Qinghua Liu, Claes Wahlestedt, Chuan He, Peng Jin
    posted by 2 people kengg jyuh
  • Global identification of microRNA-target RNA pairs by parallel analysis of RNA ends.
    Nature biotechnology (9 June 2008)
    by Marcelo A A German, Manoj Pillay, Dong-Hoon H Jeong, Amit Hetawal, Shujun Luo, Prakash Janardhanan, Vimal Kannan, Linda A A Rymarquis, Kan Nobuta, Rana German, Emanuele De Paoli, Cheng Lu, Gary Schroth, Blake C C Meyers, Pamela J J Green
    posted by 3 people stajich Berkeley Mycology megraw
  • Erratum: HIV vaccine controversy
    Nature Biotechnology, Vol. 26, No. 8., pp. 947-947.
    by KS Jayaraman
  • Erratum: Response to HIV vaccine trials in India
    Nature Biotechnology, Vol. 26, No. 8., pp. 947-947.
    by KS Jayaraman
  • Erratum: Can 'double blockbuster' strengthen Amgen's backbone?
    Nature Biotechnology, Vol. 26, No. 8., pp. 947-947.
    by Cormac Sheridan
  • Erratum: Biotech slumps in Q1
    Nature Biotechnology, Vol. 26, No. 8., pp. 947-947.
    by Stacy Lawrence
  • Westernizing Eastern-bloc science
    Nature Biotechnology, Vol. 26, No. 8., pp. 949-950.
    by Quirin Schiermeier
  • [euro]2 billion IMI launched with European pharma
    Nature Biotechnology, Vol. 26, No. 7., pp. 717-718.
    by John Hodgson
    posted by 1 person reyez
  • Dyax backs albumin
    Nature Biotechnology, Vol. 26, No. 7., pp. 718-718.
    by Mark Ratner
  • Commercial interest waxes for IGF-1 blockers
    Nature Biotechnology, Vol. 26, No. 7., pp. 719-720.
    by Randy Osborne
    posted by 1 person reyez
  • Meta-analysis torpedoes blood substitutes
    Nature Biotechnology, Vol. 26, No. 7., pp. 721-723.
    by Charlie Schmidt
  • UK passes hybrids
    Nature Biotechnology, Vol. 26, No. 7., pp. 721-721.
    by Nuala Moran
  • Tighter gene tests
    Nature Biotechnology, Vol. 26, No. 7., pp. 721-721.
    by Jeff Fox
  • Biofuels, take two
    Nature Biotechnology, Vol. 26, No. 7., pp. 722-722.
    by Emily Waltz
  • 50 cancers to be sequenced
    Nature Biotechnology, Vol. 26, No. 7., pp. 722-722.
    by Henry Nicholls
    posted by 1 person reyez
    • Remarque: pour citer cette page, utilisez l'url suivante: http://www.citeulike.org/journal/nature-biotechnology

    Result page: 1 2 3 4 5 6 7 8 9 10 Next RIS BibTeX
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.